作者：
Faner,R. [1]
;
Tal-Singer,R. [2]
;
Riley,J.H. [3]
;
Celli,B. [4]
;
Vestbo,J. [5]
;
MacNee,W. [6]
;
Bakke,P. [7]
;
Calverley,P.M.A. [8]
;
Coxson,H. [9]
;
Crim,C. [10]
;
Edwards,L.D. [11]
;
Locantore,N. [12]
;
Lomas,D.A. [13]
;
Miller,B.E. ;
Rennard,S.I. ;
Wouters,E.F.M. ;
Yates,J.C. ;
Silverman,E.K. ;
Agusti,A.
作者单位：
Department of Thoracic Medicine, Institute of Clinical Science, University of Bergen, Bergen, Norway
[1]
Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, Netherlands
[2]
Division of Infection and Immunity Clinical Sciences Centre, University Hospital Aintree, Liverpool
[3]
GlaxoSmithKline Research and Development, Research Triangle Park, NC, United States
[4]
Channing Division of Network Medicine and Pulmonary and Critical Care Division, Brigham and Women's
[5]
Department of Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC
[6]
GlaxoSmithKline Research and Development, King of Prussia, PA, United States
[7]
Department of Respiratory Medicine, Odense University Hospital, University of Southern Denmark
[8]
Fundació Investigació Sanitària Illes Balears (FISIB), Ciber Enfermedades Respiratorias (CIBERES),
[9]
GlaxoSmithKline Research and Development, Stevenage, United Kingdom
[10]
Division of Medicine, University College London, London, United Kingdom
[11]
Department of Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha
[12]
University of Edinburgh, MRC Centre for Inflammation Research, Queen's Medical Research Institute
[13]
发布时间
2018-10-31
换一批
